Wiley, a global leader in research and educational publishing, has partnered with OpenEvidence to integrate its vast collection of peer-reviewed medical journals and clinical content directly into OpenEvidence’s AI-powered clinical decision support platform. The collaboration aims to ensure that physicians receive evidence-based, up-to-date answers sourced from high-quality, trusted publications during patient encounters, enhancing the reliability and accuracy of AI-generated clinical insights.
Glimpse:
Through the partnership, OpenEvidence’s generative AI system now pulls real-time information from Wiley’s extensive portfolio including journals like The Lancet, JAMA Network, Annals of Internal Medicine, and others to provide fully referenced, citation-backed responses to clinical queries. Physicians can access guideline summaries, trial data, drug information, and diagnostic reasoning with transparent sourcing, reducing reliance on potentially outdated or unverified knowledge. The integration is live for OpenEvidence users in the U.S. and expanding globally, with both companies emphasizing rigorous validation, bias mitigation, and compliance with regulatory standards.
Wiley, one of the world’s foremost publishers of peer-reviewed scientific and medical content, has entered into a strategic partnership with OpenEvidence, the AI-powered clinical intelligence platform widely used by U.S. physicians. Announced on February 27, 2026, the collaboration integrates Wiley’s authoritative journal articles, clinical reviews, guidelines, and evidence-based resources directly into OpenEvidence’s real-time query engine, ensuring that every AI-generated clinical response is grounded in the most current and rigorously vetted medical literature.
OpenEvidence’s platform allows physicians to ask complex questions during or between patient encounters such as treatment options for rare conditions, latest guideline updates, or management of drug interactions and receive concise, actionable answers in seconds. With the Wiley integration, these responses now include direct citations from high-impact journals, full-text excerpts where licensed, and links to original publications for deeper review. This addresses a key limitation of many generative AI tools: the risk of outdated, incomplete, or unsourced information. Wiley’s content spans thousands of titles across oncology, cardiology, neurology, infectious diseases, and primary care, providing comprehensive coverage for the majority of clinical scenarios encountered in practice.
Both companies emphasized rigorous safeguards to maintain scientific integrity. All AI outputs are traceable to primary sources, confidence scores are displayed, and responses are flagged when evidence is limited or evolving. The partnership includes ongoing content updates to reflect new publications and guideline revisions, as well as joint efforts to monitor for potential biases in interpretation or representation of underrepresented populations in medical literature. The integration is designed to comply fully with HIPAA, copyright laws, and emerging AI transparency requirements from bodies like the FDA and CMS.
Early feedback from OpenEvidence users including academic medical centers, community hospitals, and large multispecialty groups has been overwhelmingly positive. Physicians report greater confidence in AI-assisted decisions, reduced time spent searching databases, and improved adherence to the latest evidence-based practices. Wiley and OpenEvidence plan to expand the partnership with additional content licensing, joint research on AI accuracy in clinical reasoning, and educational initiatives to train clinicians on effective use of evidence-backed AI tools.
The collaboration reflects a broader industry shift toward grounding generative AI in peer-reviewed literature to build trust and reliability in clinical applications. As AI increasingly supports point-of-care decision-making, partnerships like this are expected to become standard for ensuring that technology amplifies rather than undermines the scientific foundation of medicine.
“Trustworthy AI in medicine requires trustworthy sources. By bringing Wiley’s peer-reviewed content directly into OpenEvidence, we are giving clinicians instant access to the highest-quality evidence at the moment it matters most.”
By
HB Team
Related News
